Načítá se...
Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19
BACKGROUND AND AIMS: Liver involvement is common in COVID-19. Elevated aspartate and alanine amino transaminase (AST/ALT) and borderline increase in serum bilirubin and serum alkaline phosphatase (ALP) are the commonest findings. Patients with associated co morbid conditions like obesity, cardiovasc...
Uloženo v:
| Vydáno v: | Diabetes Metab Syndr |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Diabetes India. Published by Elsevier Ltd.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7834636/ https://ncbi.nlm.nih.gov/pubmed/32540736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dsx.2020.06.013 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|